Beloxepin

Drug Profile

Beloxepin

Alternative Names: ADL 6906; ORG 4428

Latest Information Update: 15 Dec 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Developer Cubist Pharmaceuticals; Organon
  • Class Analgesics; Antidepressants; Antineoplastics; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Major depressive disorder; Pain

Most Recent Events

  • 15 Dec 2011 Discontinued - Phase-I for Pain in USA (PO)
  • 12 Dec 2011 Adolor Corporation has been acquired and merged into Cubist Pharmaceuticals
  • 11 Nov 2010 Adolor Corporation acquires rights to access data on beloxepin from Organon
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top